Additionally, myricetin and rutin have been shown to modulate various diseases, including diabetes, atherosclerosis, and inflammation-related disorders, through the STAT3, AKT1, and PIK3R1 signaling pathways. This evidence concerns the gene AKT1 and diabetes mellitus.